Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age

BACKGROUND: Plasmodium falciparum malaria is a pressing global health problem. A previous study of the malaria vaccine RTS,S (which targets the circumsporozoite protein), given with an adjuvant system (AS02A), showed a 30% rate of protection against clinical malaria in children 1 to 4 years of age....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bejon, Philip, Lusingu, John, Olotu, Ally, Leach, Amanda, Lievens, Marc, Vekemans, Johan, Mshamu, Salum, Lang, Trudie, Gould, Jayne, Dubois, Marie-Claude, Demoitié, Marie-Ange, Stallaert, Jean-Francois, Vansadia, Preeti, Carter, Terrell, Njuguna, Patricia, Awuondo, Ken O., Malabeja, Anangisye, Abdul, Omar, Gesase, Samwel, Mturi, Neema, Drakeley, Chris J., Savarese, Barbara, Villafana, Tonya, Ballou, W. Ripley, Cohen, Joe, Riley, Eleanor M., Lemnge, Martha M., Marsh, Kevin, von Seidlein, Lorenz
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2655100/
https://ncbi.nlm.nih.gov/pubmed/19064627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0807381
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados